We use cookies for a better user experience. Read our Privacy Policy

I Agree

Radiation Dermatitis Market Forecast, 2020-2030

Radiation Dermatitis Market (Product: Oral Medication, Topical, and Dressings; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Retail Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

Contingency Plans Drive Production Activities amid Coronavirus Uncertainties

Rapid development and testing of COVID-19 vaccines from India have reduced the stress on healthcare companies to innovate in therapeutics that treat the novel infection. However, bottom lines in the healthcare industry are gradually reviving with growth in consumer spend. Companies in the radiation dermatitis market are becoming aware about special policies reserved for healthcare as an essential industry amid the ongoing coronavirus era.

Due to a decline in consumer spending, stakeholders in the value chain are being affected due to delayed shipment of raw materials and disruptions in supply chains. Hence, companies in the radiation dermatitis market are adopting contingency plans to stay flexible in production and distribution activities. They are maintaining high inventory levels to avoid supply shocks for essential medications required for radiation dermatitis.

radiation dermatitis market segmentation

To know the scope of our report Get a Sample on Radiation Dermatitis Market

New Biocompatible, Biodegradable Nanomaterials Pave Way for Innovations in Dressings

The radiation dermatitis market is expected to reach a valuation of ~US$ 700 Mn by the end of 2030. Manufacturers are boosting their output capacities in wound dressings that are highly elastic and flexible in nature. However, it has been found that these dressings in some cases may damage fragile skin and may not prevent maceration. This has created a need for new biocompatible and biodegradable nanomaterials that help in regulating all phases of wound healing.

Companies in the radiation dermatitis market are increasing their R&D capabilities to develop dressings that incorporate antibacterial and self-healing properties.

Get a glimpse of the in-depth analysis through our Report Brochure

Non-steroidal Ingredients in Creams Ameliorate Radiation Dermatitis Symptoms

Adverse effects of any radiation therapy, such as in the case of breast cancer, may lead to issues such as skin irritation, tenderness in treated area, and changes in skin color. In order to minimize these adverse effects, manufacturers in the radiation dermatitis market are innovating in corticosteroid creams and ointments. Topical sucralfate or hyaluronic acid hold promising potentials in ameliorating the symptoms of patients suffering from radiation dermatitis.

Herbal ingredients such as extracts from the calendula plant are gaining prominence in corticosteroid creams and ointments for topical applications. Patients are preferring non-steroidal ingredients in creams. This explains why the radiation dermatitis market is projected to expand at a modest CAGR of ~5% during the assessment period.

Traditional Chinese Medicine Holds Potential in Treatment of Carbuncles Post Radiotherapy

Traditional Chinese medicine (TCM), Jiawei Simiao Yongan Gao, holds promising potentials in minimizing the impact of radio-dermatitis in patients with neck and head cancer. Companies in the radiation dermatitis market are capitalizing on this opportunity to innovate in pastes that improve the symptoms of skin reaction caused due to radiotherapy. They are improving their production capabilities in clear and light drugs that can enter the lung meridian directly.

Honeysuckle is emerging as one of the key ingredients in TCM for the treatment of carbuncles. Manufacturers in the radiation dermatitis market are experimenting with medicines containing angelica sinensis, which appears to nourish and activate the blood and relieve pain by promoting coronary circulation.

Film-forming Gel a Breakthrough Innovation for Enabling Faster Wound Healing

Innovations in wound dressings are creating value grab opportunities for companies in the radiation dermatitis market. Stratpharma - a pharmaceutical company in Basel, Switzerland, has introduced its StrataXRT® innovative and film-forming wound dressing gel that easily spreads with only a small amount applied on the affected area of the skin. Companies in the radiation dermatitis market are taking cues from such companies to develop film-forming gels that provide symptomatic relief from acute inflammatory response, discomfort, and itching.

Film-forming gels are a game changer in the class of wound dressings that reduce redness and swelling post exposure toward radiotherapy. Such gels are being used to protect the compromised skin from microbial invasion and prevent bacterial growth. Thus, film-forming wound dressing gels are creating an optimum environment for reducing downtime and enable faster wound healing.

radiation dermatitis market infographic

Expanding operations in future? To get the perfect launch ask for a custom report

Analysts’ Viewpoint

Companies in the radiation dermatitis market are focusing on continuous R&D innovations to grab the attention of consumers and offer alternate treatment options during the ongoing coronavirus pandemic. Film-forming wound dressing gels are bringing a significant change in the market landscape, since they reduce downtime and enable fast re-epithelialization. However, manufacturers are learning about side effects such as infection and skin atrophy after the application of topical steroids. Hence, companies should adopt traditional Chinese medicine ingredients such as raw astragalus and herbal extracts of the calendula plant to minimize adverse events after the application of creams and ointments. New biocompatible and biodegradable materials are being used to innovate in advanced wound dressings.

Radiation Dermatitis Market: Overview

  • According to Transparency Market Research’s latest report on the global radiation dermatitis market for the historical year 2018 and forecast period 2020-2030, rise in prevalence of cancer and increase in adoption of radiation therapy for cancer treatment are projected to drive the global radiation dermatitis market during the forecast period
  • According to the report, the global radiation dermatitis market was valued at ~US$ 400 Mn in 2019 and is anticipated to expand at a CAGR of ~5% from 2020 to 2030

Rise in Prevalence of Cancer: Key Driver

  • According to the International Agency for Research on Cancer (IARC) estimates on the global cancer burden (December 2020), the number of new cancer cases is likely to rise to 19.3 million, with 10 million cancer deaths in 2020. This depicts 1 in 5 people develop cancer during their lifetime, and 1 in 8 men and 1 in 11 women succumb to the disease.
  • By 2040, the number of new cancer cases per year is expected to rise to 29.5 million and the number of cancer-related deaths to 16.4 million
  • Generally, cancer rates are the highest in countries whose populations have the highest life expectancy, education level, and standard of living. However, for some cancer types, such as cervical cancer, the reverse is true, and the incidence rate is highest in countries in which the population ranks low on these measures.
  • According to the Union for International Cancer Control (UICC), for the first time in 2020, breast cancer has become the most commonly diagnosed cancer surpassing lung cancer, in particular due to high prevalence in low- and middle-income countries (LMICs). Lung cancer is the leading cause of cancer deaths, not only in many LMICs, but also in most higher-income regions such as North America, Europe, and Australia.
  • According to the World Cancer Research Fund International, breast cancer is the most commonly occurring cancer overall. There were over 2 million new cases globally in 2018. Belgium, Luxembourg, and the Netherlands are the top three countries with highest rate of breast cancer in women globally.
  • According to the National Cancer Institute at the National Institutes of Health (NIH), an estimated 1,806,590 new cases of cancer will be diagnosed in the U.S. and 606,520 people will succumb to the disease in 2020
  • According to the World Cancer Research Fund International (WCRF), top 12 countries in the world with highest cancer rate in 2018 were Australia, New Zealand, Ireland, Hungary, the U.S., Belgium, France (metropolitan), Denmark, Norway, the Netherlands, Canada, and New Caledonia (France); of these, Australia is at the top with the highest cancer rate of 468 people per 100,000.

Surge in Adoption of Radiation Therapy to Boost Market Growth

  • Radiation therapy (also called radiotherapy) is a highly effective cancer treatment with wide-ranging uses. Radiation therapy cures cancer in patients (either alone or with other treatments) and relieves symptoms or prolongs survival in more advanced cancers.
  • Radiation therapy contributes to 40% of all cancer cures globally as well as improving the quality of life for many others
  • Increase in utilization of radiation therapy, owing to targeted treatment for controlling cancer and consistency in treatment protocols across multiple centers have resulted in rise in prevalence of radiation dermatitis
  • According to statistics presented by the American Society for Radiation Oncology, nearly 95% of patients receiving radiation therapy suffer from some degree of radiation dermatitis, whereas 85% of the total patient base experiences severe to moderate radiation dermatitis that requires intensive treatment. This is expected to propel the global radiation dermatitis market over the next few years.
  • Not all cancers can be treated with a single type of therapy, and hence, a combination of chemotherapy and radiation is often used in situations where the intent is curative and not palliative care. Patients who receive chemotherapy as well as radiation therapy have higher chance of developing radiation dermatitis.
  • The plausible upsurge in combination therapy clinical trials and treatments in future is anticipated to lead to rise in patients suffering from radiation dermatitis. This, in turn, is likely to drive the market.
  • For some cancers that are too advanced to be cured, radiation therapy is quite effective for pain and other problems, such as bleeding from the lung or bladder. For instance, pain in the bones from the spread of cancer can be improved significantly or be completely removed in around 75% of patients. This is projected to augment the global radiation dermatitis market.

Introduction of Better Radiation Therapy Equipment to Hamper Market

  • Severity and likeliness to develop radiation dermatitis can be either patient-related or treatment-related. Treatment-related factors include the type and quality of radiation beam and the location and size of the treatment field.
  • Modern radiotherapy techniques, which include intensity-modulated radiation therapy (IMRT) and proton therapy, can diminish the risk for radiation dermatitis by more accurately targeting tumor, thereby saving the normal tissue from repeated assault
  • Higher adoption of these techniques, especially in developed regions such as the U.S. and Europe, can lead to fewer severe rated cases of radiation dermatitis. This is likely to restrain the global market.

Radiation Dermatitis Market: Competition Landscape

  • This report profiles major players in the global radiation dermatitis market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • Leading players operating in the global radiation dermatitis market are
    • 3M Company
    • Mölnlycke Health Care AB
    • Smith & Nephew plc
    • Integra Lifesciences Holdings Corporation
    • Intermed S.A.
    • ConvaTec Group plc
    • BMG PHARMA S.p.A.

Radiation Dermatitis Market: Key Developments

  • Key players in the global radiation dermatitis market are engaged in regulatory approvals, development of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global radiation dermatitis market over the next few year. A few expansion strategies adopted by players operating in the global radiation dermatitis market are:
    • In January 2021, Integra LifeSciences Holdings Corporation completed the acquisition of ACell, Inc. This acquisition will enable Integra to provide more comprehensive complex wound management solutions.
    • In February 2020, Integra LifeSciences launched AmnioExcel Plus Placental Allograft Membrane, its latest wound care offering to support soft tissue repair. AmnioExcel Plus is a next generation, thicker, tri-layer, non-side specific allograft consisting of amnion-chorion-amnion layers that aids in creating an environment to help close complex wounds.
    • In June 2019, Mölnlycke and Zuellig Pharma announced a partnership to focus on providing more advanced wound care products and solutions to patients and healthcare practitioners across Southeast Asia. This strategic partnership follows Mölnlycke’s acquisition of SastoMed in July 2018, augmenting Mölnlycke’s range of wound care solutions with SastoMed’s ground-breaking, oxygen-therapy-based solutions for chronic wounds (via its products Granulox and Granudacyn).
    • In November 2018, the company launched Mepilex Border Flex at the Symposium on Advanced Wound Care Fall meeting in Las Vegas. The Mepilex Border Flex dressing was specifically engineered to support fewer dressing changes, reducing dressing cost and waste, while creating an optimal healing environment.
    • In July 2018, ConvaTec received the U.S. Food and Drug Administration (FDA) 510(k) clearance for its AQUACEL Ag Advantage dressing for wound management
  • The report on the global radiation dermatitis market discussed individual strategies, followed by company profiles of treatment providers of radiation dermatitis. The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global radiation dermatitis market.

Radiation Dermatitis Market – Segmentation

Product

  • Oral Medication
    • Corticosteroids
    • Oral analgesics & Antibiotics
  • Topical
    • Corticosteroids
    • Hydrophilic Creams
    • Topical Antibiotics
  • Dressings
    • Hydrogel
    • Hydrocolloid
    • No Sting Barrier film
    • Honey Impregnated Gauze
    • Silicone Coated Dressing
    • Others
Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Interested in this report?
Get a FREE sample now!

Get Free Sample

*Get Sample Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of radiation dermatitis market?

The global radiation dermatitis market was worth US$ 400 Mn and is projected to reach a value of US$ 700 Mn by the end of 2030

What is the anticipated CAGR of the radiation dermatitis market in the forecast period?

Radiation dermatitis market is anticipated to grow at a CAGR of 5% during the forecast period

Which region is expected to project the highest market share in radiation dermatitis market?

Asia Pacific accounted for a major share of the global radiation dermatitis market

What are the key driving factors for the growth of radiation dermatitis market?

Radiation dermatitis market is driven by rise in prevalence of cancer and increase in adoption of radiation therapy for cancer treatment are projected to drive the global market during the forecast period

Who are the key players in the global radiation dermatitis market?

Key players in the global radiation dermatitis market include 3M Company, Mölnlycke Health Care AB, Smith & Nephew plc, Integra Lifesciences Holdings Corporation, Intermed S.A., ConvaTec Group plc, and BMG PHARMA S.p.A.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Radiation Dermatitis Market 

4. Market Overview

    4.1. Introduction

        4.1.1. Definition

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Radiation Dermatitis Market Analysis and Forecast, 2018–2030

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Pipeline Analysis

    5.2. Key Industry Events

    5.3. Overview & Prevalence of Disease

    5.4. COVID-19 Pandemic Impact on Industry

6. Global Radiation Dermatitis Market Analysis and Forecast, by Product 

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value & Volume Forecast, by Product, 2018–2030

        6.3.1. Oral Medication

            6.3.1.1. Corticosteroids

            6.3.1.2. Oral Analgesics & Antibiotics

        6.3.2. Topical

            6.3.2.1. Corticosteroids

            6.3.2.2. Hydrophilic Creams

            6.3.2.3. Topical Antibiotics

        6.3.3. Dressings

            6.3.3.1. Hydrogel

            6.3.3.2. Hydrocolloid

            6.3.3.3. No Sting Barrier film 

            6.3.3.4. Honey Impregnated Gauze

            6.3.3.5. Silicone Coated Dressing

            6.3.3.6. Others

    6.4. Market Attractiveness Analysis, by Product 

7. Global Radiation Dermatitis Market Analysis and Forecast, by Distribution Channel 

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value & Volume Forecast, by Distribution Channel, 2018–2030

        7.3.1. Hospital Pharmacies

        7.3.2. Retail Pharmacies

        7.3.3. Online Pharmacies

    7.4. Market Attractiveness Analysis, by Distribution Channel 

8. Global Radiation Dermatitis Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Market Value & Volume Forecast, by Region

        8.2.1. North America 

        8.2.2. Europe 

        8.2.3. Asia Pacific 

        8.2.4. Latin America 

        8.2.5. Middle East & Africa 

    8.3. Market Attractiveness Analysis, by Country/Region

9. North America Radiation Dermatitis Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value & Volume Forecast, by Product, 2018–2030

        9.2.1. Oral Medication

            9.2.1.1. Corticosteroids

            9.2.1.2. Oral Analgesics & Antibiotics

        9.2.2. Topical

            9.2.2.1. Corticosteroids

            9.2.2.2. Hydrophilic Creams

            9.2.2.3. Topical Antibiotics

        9.2.3. Dressings

            9.2.3.1. Hydrogel

            9.2.3.2. Hydrocolloid

            9.2.3.3. No Sting Barrier film 

            9.2.3.4. Honey Impregnated Gauze

            9.2.3.5. Silicone Coated Dressing

            9.2.3.6. Others

    9.3. Market Value & Volume Forecast, by Distribution Channel, 2018–2030

        9.3.1. Hospital Pharmacies

        9.3.2. Retail Pharmacies

        9.3.3. Online Pharmacies

    9.4. Market Value & Volume Forecast, by Country, 2018–2030

        9.4.1. U.S.

        9.4.2. Canada

    9.5. Market Attractiveness Analysis 

        9.5.1. By Product 

        9.5.2. By Distribution Channel 

        9.5.3. By Country

10. Europe Radiation Dermatitis Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value & Volume Forecast, by Product, 2018–2030

        10.2.1. Oral Medication

            10.2.1.1. Corticosteroids

            10.2.1.2. Oral Analgesics & Antibiotics

        10.2.2. Topical

            10.2.2.1. Corticosteroids

            10.2.2.2. Hydrophilic Creams

            10.2.2.3. Topical Antibiotics

        10.2.3. Dressings

            10.2.3.1. Hydrogel

            10.2.3.2. Hydrocolloid

            10.2.3.3. No Sting Barrier film 

            10.2.3.4. Honey Impregnated Gauze

            10.2.3.5. Silicone Coated Dressing

            10.2.3.6. Others

    10.3. Market Value & Volume Forecast, by Distribution Channel, 2018–2030

        10.3.1. Hospital Pharmacies

        10.3.2. Retail Pharmacies

        10.3.3. Online Pharmacies

    10.4. Market Value & Volume Forecast, by Country/Sub-Region, 2018–2030

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Spain

        10.4.5. Italy

        10.4.6. Rest of Europe

    10.5. Market Attractiveness Analysis 

        10.5.1. By Product 

        10.5.2. By Distribution Channel 

        10.5.3. By Country/Sub-Region

11. Asia Pacific Radiation Dermatitis Market Analysis and Forecast

    11.1.Introduction

        11.1.1. Key Findings

    11.2.Market Value & Volume Forecast, by Product, 2018–2030

        11.2.1. Oral Medication

            11.2.1.1. Corticosteroids

            11.2.1.2. Oral Analgesics & Antibiotics

        11.2.2. Topical

            11.2.2.1. Corticosteroids

            11.2.2.2. Hydrophilic Creams

            11.2.2.3. Topical Antibiotics

        11.2.3. Dressings

            11.2.3.1. Hydrogel

            11.2.3.2. Hydrocolloid

            11.2.3.3. No Sting Barrier film 

            11.2.3.4. Honey Impregnated Gauze

            11.2.3.5. Silicone Coated Dressing

            11.2.3.6. Others

    11.3.Market Value & Volume Forecast, by Distribution Channel, 2018–2030

        11.3.1. Hospital Pharmacies

        11.3.2. Retail Pharmacies

        11.3.3. Online Pharmacies

    11.4.Market Value & Volume Forecast, by Country/Sub-Region, 2018–2030

        11.4.1. China

        11.4.2. Japan

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific

    11.5.Market Attractiveness Analysis 

        11.5.1. By Product 

        11.5.2. By Distribution Channel 

        11.5.3. By Country/Sub-Region

12. Latin America Radiation Dermatitis Market Analysis and Forecast

    12.1.Introduction

        12.1.1. Key Findings

    12.2.Market Value & Volume Forecast, by Product, 2018–2030

        12.2.1. Oral Medication

            12.2.1.1. Corticosteroids

            12.2.1.2. Oral Analgesics & Antibiotics

        12.2.2. Topical

            12.2.2.1. Corticosteroids

            12.2.2.2. Hydrophilic Creams

            12.2.2.3. Topical Antibiotics

        12.2.3. Dressings

            12.2.3.1. Hydrogel

            12.2.3.2. Hydrocolloid

            12.2.3.3. No Sting Barrier film 

            12.2.3.4. Honey Impregnated Gauze

            12.2.3.5. Silicone Coated Dressing

            12.2.3.6. Others

    12.3.Market Value & Volume Forecast, by Distribution Channel, 2018–2030

        12.3.1. Hospital Pharmacies

        12.3.2. Retail Pharmacies

        12.3.3. Online Pharmacies

    12.4.Market Value & Volume Forecast, by Country/Sub-Region, 2018–2030

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America

12.5.Market Attractiveness Analysis 

        12.5.1. By Product 

        12.5.2. By Distribution Channel 

        12.5.3. By Country/Sub-Region

13. Middle East & Africa Radiation Dermatitis Market Analysis and Forecast

    13.1.Introduction

        13.1.1. Key Findings

    13.2.Market Value & Volume Forecast, by Product, 2018–2030

        13.2.1. Oral Medication

            13.2.1.1. Corticosteroids

            13.2.1.2. Oral Analgesics & Antibiotics

        13.2.2. Topical

            13.2.2.1. Corticosteroids

            13.2.2.2. Hydrophilic Creams

            13.2.2.3. Topical Antibiotics

        13.2.3. Dressings

            13.2.3.1. Hydrogel

            13.2.3.2. Hydrocolloid

            13.2.3.3. No Sting Barrier film 

            13.2.3.4. Honey Impregnated Gauze

            13.2.3.5. Silicone Coated Dressing

            13.2.3.6. Others

    13.3.Market Value & Volume Forecast, by Distribution Channel, 2018–2030

        13.3.1. Hospital Pharmacies

        13.3.2. Retail Pharmacies

        13.3.3. Online Pharmacies

    13.4.Market Value & Volume Forecast, by Country/Sub-Region, 2018–2030

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East & Africa

    13.5.Market Attractiveness Analysis 

        13.5.1. By Product 

        13.5.2. By Distribution Channel 

        13.5.3. By Country/Sub-Region

14. Competition Landscape

    14.1. Market Player – Competition Matrix (by tier and size of companies)

    14.2. Company Profiles

        14.2.1. 3M Company 

            14.2.1.1. by tier

            14.2.1.2. size of companies

        14.2.2. Mölnlycke Health Care AB 

            14.2.2.1. by tier

            14.2.2.2. size of companies

        14.2.3. Smith & Nephew plc 

            14.2.3.1. by tier

            14.2.3.2. size of companies

        14.2.4. Integra Lifesciences Holdings Corporation 

            14.2.4.1. by tier

            14.2.4.2. size of companies

        14.2.5. Intermed S.A. 

            14.2.5.1. by tier

            14.2.5.2. size of companies

        14.2.6. ConvaTec Group plc 

            14.2.6.1. by tier

            14.2.6.2. size of companies

        14.2.7. BMG PHARMA S.p.A. 

            14.2.7.1. by tier

            14.2.7.2. size of companies

List of Tables

Table 01: Global Radiation Dermatitis Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 02: Global Radiation Dermatitis Market Value (US$ Mn) Forecast, by Oral Medication, 2018–2030

Table 03: Global Radiation Dermatitis Market Value (US$ Mn) Forecast, by Topical, 2018–2030

Table 04: Global Radiation Dermatitis Market Value (US$ Mn) Forecast, by Dressings, 2018–2030

Table 05: Global Radiation Dermatitis Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 06: Global Radiation Dermatitis Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 07: North America Radiation Dermatitis Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 08: North America Radiation Dermatitis Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 09: North America Radiation Dermatitis Market Value (US$ Mn) Forecast, by Oral Medication, 2018–2030

Table 10: North America Radiation Dermatitis Market Value (US$ Mn) Forecast, by Topical, 2018–2030

Table 11: North America Radiation Dermatitis Market Value (US$ Mn) Forecast, by Dressings, 2018–2030

Table 12: North America Radiation Dermatitis Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 13: Europe Radiation Dermatitis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 14: Europe Radiation Dermatitis Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 15: Europe Radiation Dermatitis Market Value (US$ Mn) Forecast, by Oral Medication, 2018–2030

Table 16: Europe Radiation Dermatitis Market Value (US$ Mn) Forecast, by Topical, 2018–2030

Table 17: Europe Radiation Dermatitis Market Value (US$ Mn) Forecast, by Dressings, 2018–2030

Table 18: Europe Radiation Dermatitis Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 19: Asia Pacific Radiation Dermatitis Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2018–2030

Table 20: Asia Pacific Radiation Dermatitis Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 21: Asia Pacific Radiation Dermatitis Market Value (US$ Mn) Forecast, by Oral Medication, 2018–2030

Table 22: Asia Pacific Radiation Dermatitis Market Value (US$ Mn) Forecast, by Topical, 2018–2030

Table 23: Asia Pacific Radiation Dermatitis Market Value (US$ Mn) Forecast, by Dressings, 2018–2030

Table 24: Asia Pacific Radiation Dermatitis Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 25: Latin America Radiation Dermatitis Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2018–2030

Table 26: Latin America Radiation Dermatitis Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 27: Latin America Radiation Dermatitis Market Value (US$ Mn) Forecast, by Oral Medication, 2018–2030

Table 28: Latin America Radiation Dermatitis Market Value (US$ Mn) Forecast, by Topical, 2018–2030

Table 29: Latin America Radiation Dermatitis Market Value (US$ Mn) Forecast, by Dressings, 2018–2030

Table 30: Latin America Radiation Dermatitis Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

Table 31: Middle East & Africa Radiation Dermatitis Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2018–2030

Table 32: Middle East & Africa Radiation Dermatitis Market Value (US$ Mn) Forecast, by Product, 2018–2030

Table 33: Middle East & Africa Radiation Dermatitis Market Value (US$ Mn) Forecast, by Oral Medication, 2018–2030

Table 34: Middle East & Africa Radiation Dermatitis Market Value (US$ Mn) Forecast, by Topical, 2018–2030

Table 35: Middle East & Africa Radiation Dermatitis Market Value (US$ Mn) Forecast, by Dressings, 2018–2030

Table 36: Middle East & Africa Radiation Dermatitis Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030

List of Figure

Figure 01: Global Radiation Dermatitis Market Value (US$ Mn) Forecast, 2018–2030

Figure 02: Global Radiation Dermatitis Market Value Share, by Product, 2019

Figure 03: Global Radiation Dermatitis Market Value Share, by Distribution Channel, 2019

Figure 04: Global Radiation Dermatitis Market Value Share, by Region, 2019

Figure 05: Global Radiation Dermatitis Market Value Share Analysis, by Product, 2019 and 2030

Figure 06: Global Radiation Dermatitis Market Attractiveness Analysis, by Product, 2020–2030

Figure 07: Global Radiation Dermatitis Market Value (US$ Mn), by Oral Medication, 2018–2030

Figure 08: Global Radiation Dermatitis Market Value (US$ Mn), by Topical, 2018–2030

Figure 09: Global Radiation Dermatitis Market Value (US$ Mn), by Dressings, 2018–2030

Figure 10: Global Radiation Dermatitis Market Value Share Analysis, by Distribution Channel, 2019 and 2030

Figure 11: Global Radiation Dermatitis Market Attractiveness Analysis, by Distribution Channel, 2020–2030

Figure 12: Global Radiation Dermatitis Market Value (US$ Mn), by Hospital Pharmacies, 2018–2030

Figure 13: Global Radiation Dermatitis Market Value (US$ Mn), by Retail Pharmacies, 2018–2030

Figure 14: Global Radiation Dermatitis Market Value (US$ Mn), by Online Pharmacies, 2018–2030

Figure 15: Global Radiation Dermatitis Market Attractiveness Analysis, by Region, 2019 and 2030

Figure 16: Global Radiation Dermatitis Market Value Share Analysis, by Region, 2020–2030

Figure 17: North America Radiation Dermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 18: North America Radiation Dermatitis Market Value Share Analysis, by Country, 2019 and 2030

Figure 19: North America Radiation Dermatitis Market Attractiveness Analysis, by Country, 2019–2030

Figure 20: North America Radiation Dermatitis Market Value Share Analysis, by Product, 2019 and 2030

Figure 21: North America Radiation Dermatitis Market Attractiveness Analysis, by Product, 2020–2030

Figure 22: North America Radiation Dermatitis Market Value Share Analysis, by Distribution Channel, 2019 and 2030

Figure 23: North America Radiation Dermatitis Market Attractiveness Analysis, by Distribution Channel, 2019–2030

Figure 24: Europe Radiation Dermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 25: Europe Radiation Dermatitis Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 26: Europe Radiation Dermatitis Market Attractiveness Analysis, by Country/Sub-region, 2019–2030

Figure 27: Europe Radiation Dermatitis Market Value Share Analysis, by Product, 2019 and 2030

Figure 28: Europe Radiation Dermatitis Market Attractiveness Analysis, by Product, 2020–2030

Figure 29: Europe Radiation Dermatitis Market Value Share Analysis, by Distribution Channel, 2019 and 2030

Figure 30: Europe Radiation Dermatitis Market Attractiveness Analysis, by Distribution Channel, 2019–2030

Figure 31: Asia Pacific Radiation Dermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 32: Asia Pacific Radiation Dermatitis Market Value Share Analysis, by Country/Sub-Region, 2019 and 2030

Figure 33: Asia Pacific Radiation Dermatitis Market Attractiveness Analysis, by Country/Sub-Region, 2019–2030

Figure 34: Asia Pacific Radiation Dermatitis Market Value Share Analysis, by Product, 2019 and 2030

Figure 35: Asia Pacific Radiation Dermatitis Market Attractiveness Analysis, by Product, 2020–2030

Figure 36: Asia Pacific Radiation Dermatitis Market Value Share Analysis, by Distribution Channel, 2019 and 2030

Figure 37: Asia Pacific Radiation Dermatitis Market Attractiveness Analysis, by Distribution Channel, 2019–2030

Figure 38: Latin America Radiation Dermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 39: Latin America Radiation Dermatitis Market Value Share Analysis, by Country/Sub-Region, 2019 and 2030

Figure 40: Latin America Radiation Dermatitis Market Attractiveness Analysis, by Country/Sub-Region, 2019–2030

Figure 41: Latin America Radiation Dermatitis Market Value Share Analysis, by Product, 2019 and 2030

Figure 42: Latin America Radiation Dermatitis Market Attractiveness Analysis, by Product, 2020–2030

Figure 43: Latin America Radiation Dermatitis Market Value Share Analysis, by Distribution Channel, 2019 and 2030

Figure 44: Latin America Radiation Dermatitis Market Attractiveness Analysis, by Distribution Channel, 2019–2030

Figure 45: Middle East & Africa Radiation Dermatitis Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030

Figure 46: Middle East & Africa Radiation Dermatitis Market Value Share Analysis, by Country/Sub-Region, 2019 and 2030

Figure 47: Middle East & Africa Radiation Dermatitis Market Attractiveness Analysis, by Country/Sub-Region, 2019–2030

Figure 48: Middle East & Africa Radiation Dermatitis Market Value Share Analysis, by Product, 2019 and 2030

Figure 49: Middle East & Africa Radiation Dermatitis Market Attractiveness Analysis, by Product, 2020–2030

Figure 50: Middle East & Africa Radiation Dermatitis Market Value Share Analysis, by Distribution Channel, 2019 and 2030

Figure 51: Middle East & Africa Radiation Dermatitis Market Attractiveness Analysis, by Distribution Channel, 2019–2030

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

762

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved